SeaStar's QUELIMMUNE Therapy For Pediatric AKI Adopted By Hospitals In Multiple States, Adult Treatment In Pipeline

benzinga.com/partner/news/25/05/45283344/seastars-quelimmune-therapy-for-pediatric-aki-adopted-by-hospitals-in-multiple-states-adult-treatmen

Pediatric acute kidney injury (AKI) impacts approximately 4,000 children in the U.S. each year, and the prognosis for these patients is grim. The mortality rate is 50%, they spend twice as long in the ICU, and more than 30% will develop chronic kidney disease following AKI – noted…

This story appeared on benzinga.com, 2025-05-08 12:12:17.
The Entire Business World on a Single Page. Free to Use →